SCHEMBL7475596

SCHEMBL7475596

CCOC(=O)C1(c2ccc(CBr)cn2)CCCC1

nearest known ligand 0.39

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
CYP4F2 P78329 1/20 0.39
CYP4A11 Q02928 1/20 0.39
OPRM1 P35372 6/20 0.39
PRCP P42785 1/20 0.38
SIGMAR1 Q99720 1/20 0.38
OPRD1 P41143 3/20 0.38
OPRK1 P41145 3/20 0.38
SLC22A1 O15245 1/20 0.38
SLC6A4 P31645 1/20 0.38
ADRA1A P35348 1/20 0.38
KCNH2 Q12809 1/20 0.38
ALDH1A1 P00352 2/20 0.38
POLB P06746 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15167852 0.83 OPRM1 (0.39) OPRM1OPRD1OPRK1SLC22A1SLC6A4
SCHEMBL10695508 0.76 OPRM1 (0.48) OPRM1PRCPSIGMAR1OPRD1OPRK1
SCHEMBL15167296 0.74 OPRM1 (0.39) OPRM1OPRD1OPRK1SLC22A1SLC6A4
SCHEMBL27378291 0.74 OPRM1 (0.52) OPRM1PRCPSIGMAR1OPRD1OPRK1
SCHEMBL30755778 0.74 OPRM1 (0.52) OPRM1PRCPSIGMAR1OPRD1OPRK1
SCHEMBL4100450 0.73 OPRM1 (0.48) OPRM1OPRD1OPRK1SLC22A1SLC6A4
SCHEMBL27379436 0.73 OPRM1 (0.51) OPRM1PRCPSIGMAR1OPRD1OPRK1
SCHEMBL15167301 0.72 OPRM1 (0.37) OPRM1OPRD1OPRK1SLC22A1SLC6A4
SCHEMBL15168129 0.72 OPRM1 (0.37) OPRM1OPRD1OPRK1SLC22A1SLC6A4
SCHEMBL22995548 0.72 OPRM1 (0.41) OPRM1PRCPSIGMAR1OPRD1OPRK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5789415-A Azacyclic-heterocyclic compounds as angiotension II receptor antagonists PFIZER INC. (US) 1998-08-04 US disclosed
WO-1995002596-A1 AZACYCLIC-HETEROCYCLIC COMPOUNDS AS ANGIOTENSIN II RECEPTOR ANTAGONISTS PFIZER INC. (US) 1995-01-26 WO disclosed